Do Novel Psychoactive Substances Displace Established Club Drugs, Supplement Them or Act as Drugs of Initiation? The relationship between Mephedrone, Ecstasy and CocaineMoore K.a · Dargan P.I.b · Wood D.M.b · Measham F.c
aDepartment of Applied Social Science, Lancaster University, Lancaster, b Guy's and St Thomas' NHS Foundation Trust, King's Health Partners and King's College London, London, and cSchool of Applied Social Sciences, Durham University, Durham, UK
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background/Aims: To assess whether novel psychoactive substances (NPS) displace established club drugs, supplement them or act as drugs of initiation via a study of the relationship between mephedrone, ecstasy pills, cocaine and MDMA powder amongst club-goers considered to be ‘early adopters' of psychostimulant/club drug trends. Methods: In situ surveys were conducted with 308 customers in two south London gay dance clubs across 3 weekend nights in July 2010 to assess the prevalence and patterns of self-reported use of a range of illegal drugs and NPS. Results: Mephedrone was added to existing drug repertoires amongst those surveyed and acted to supplement more established club drugs including ecstasy pills, cocaine and MDMA powder, rather than replacing or displacing those drugs. Conclusion: This survey suggests that NPS are likely to be added to drug repertoires, particularly amongst experienced users with consequent health risks for individuals and resource implications for services. This study points to a complex relationship between NPS and illegal drug availability, purity and regulatory control, one which is increasingly important to understand given the global emergence of NPS and the challenges they present to existing supply, demand and harm reduction strategies.
© 2013 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.